Lisinopril and Hydrochlorothiazide
- Product NDC
- 16571-793
- 11-digit product format
- 165710793
- Labeler code
- 16571
- Product ID
- 16571-793_2f19b802-e931-471f-83f3-e116a84b1bb8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rising Pharma Holdings, Inc.
- Application
- ANDA077606
- Marketing category
- ANDA
- Marketing start
- 2006-03-14
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16571-793-01 | 16571079301 | 100 TABLET in 1 BOTTLE (16571-793-01) | 100 tablet | 2006-03-14 | 0000-00-00 | No | No | Current |
| 16571-793-50 | 16571079350 | 500 TABLET in 1 BOTTLE (16571-793-50) | 500 tablet | 2006-03-14 | 0000-00-00 | No | No | Current |